Summary by Moomoo AI
Consino Biologics Corporation issued a notice on January 30, 2024 reminding shareholders that the First Extraordinary General Meeting of the upcoming February 20, 2024 will use the cumulative voting system to elect members of the Board and Supervisory Board. The system allows shareholders to vote on candidates based on the number of holdings, with each share corresponding to the number of directors elected. Shareholders can distribute voting rights on average to all candidates or cast them centrally to a specific candidate. If the number of votes exceeds the total number of votes held by the shareholding, the vote will be invalid. Shareholders are required to submit the proxy form 24 hours prior to the appointed time of the General Meeting. Board members include Executive Director Dr. Xuefeng YU, etc., Non-Executive Directors and Independent Non-Executive Directors, etc.